Massive prognostic parameters for recurrence of PTMC have been identified in previous studies, such as male gender, age <45, ETE, multifocality, primary tumor size, BRAF, T3 tumor, and lymph node metastasis [19–27]. Here, BRAF is linked to metastatic malignant neoplasm in the lymph nodes.